Status:
COMPLETED
A Study to Evaluate Pharmacokinetics of C3G and to Estimate Antioxidative Markers After Repeated Administration of Mulberry Fruit Extract
Lead Sponsor:
Seoul St. Mary's Hospital
Collaborating Sponsors:
Rural Development Administration, Korea
Conditions:
Oxidative Stress
Eligibility:
All Genders
20-45 years
Phase:
NA
Brief Summary
This study is to evaluate pharmacokinetic-pharmacodynamic property of C3G after administration of Mulberry fruit extract to 12 healthy Korean volunteers. Plasma concentration of C3G and the antioxidat...
Eligibility Criteria
Inclusion
- Body weight \>55 kg for male, \>45 kg for female (within 80-120% of Ideal body weight)
- Give written informed consent and voluntarily decide participation
Exclusion
- Acute or chronic disease symptom on screening
- Existing active and clinically significant disease involving more than one organ system
- Known allergy to Mulberry or other berries
- Positive drug or alcohol screening
- Smokers of 10 or more cigarettes per day
- Participation in a clinical trial during last 2 month prior to the start of the study
- Pregnancy
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01230268
Start Date
November 1 2010
End Date
December 1 2010
Last Update
December 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul St.Mary's Hospital
Seoul, South Korea, 137-701